查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1799211

全球遠距藥事照護市場

Telepharmacy
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 144 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到 2030 年全球遠距藥事照護市場規模將達到 406 億美元

全球遠距藥事照護市場規模預計在2024年達到117億美元，預計在分析期內（2024-2030年）的複合年成長率為23.1%，到2030年將達到406億美元。病患諮詢服務是本報告分析的細分市場之一，預計其複合年成長率為24.6%，到分析期結束時將達到206億美元。遠距藥局服務細分市場在分析期間內的複合年成長率預計為23.5%。

美國市場規模估計為 31 億美元，中國市場預計複合年成長率為 21.8%

美國遠距藥事照護市場規模預計在2024年達到31億美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到62億美元，在2024-2030年的分析期間內，複合年成長率為21.8%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為21.5%和19.9%。在歐洲，預計德國市場的複合年成長率約為16.9%。

全球遠距藥事照護市場－主要趨勢與促進因素摘要

遠距藥事照護如何縮小醫療保健服務的差距？

遠距藥事照護使配藥、諮詢和治療監測等醫藥服務能夠透過數位平台遠端交付。藥房使用視訊通話、安全通訊和機器人配藥單元，為農村和服務不足地區（這些地區缺乏實體藥房）的患者提供服務。雲端基礎的藥房管理系統有助於處方箋驗證、電子健康記錄整合和依從性追蹤。從先導計畫到全面整合的遠距遠距藥事照護網路的轉變，反映了一種新的視角：藥局不再只是實體配藥房，而是幾乎全天候開放的醫療保健服務交付節點。

哪些技術進步推動了這項演變？

人工智慧驅動的藥物審查工具正在幫助藥劑師識別藥物交互作用並進行個人化劑量調整。自動配藥亭和遠端機械臂使遠端技術人員能夠在藥劑師的監督下監督安全配藥。遠端藥物護理應用程式提供續藥提醒、虛擬吞藥指導和慢性病生命徵象監測等功能。區塊鏈和電子處方箋系統提高了處方箋安全性和互通性，即時翻譯模組為醫療資源匱乏地區的非母語人士提供支援。這些創新正在重塑傳統的工作流程，從而提供更有效率、更高品質的患者支援。

哪些相關人員的需求推動了遠距藥事照護的採用？

行動不便或患有慢性疾病的患者受益於宅配和遠端諮詢，這減輕了出行負擔，並提高了服藥依從性。雇主和保險公司將遠距藥事照護視為確保護理連續性並降低急診就診相關成本的一種方式。面臨勞動力短缺的藥房正在利用遠距藥事照護重新分配藥劑師的時間，支援非工作時間服務，並擴大服務覆蓋範圍。衛生系統和社區醫院正在採用遠距藥事照護來遵守監管要求，在鄉村診所和夜班期間提供電子藥物核對，並提高偏遠地區患者的安全。

是什麼推動了遠距藥事照護市場的發展？

遠距藥事照護市場的成長受到多種因素的推動，包括遠端配藥和電子處方處方箋的放鬆、藥房自動化硬體投資的增加、需要持續藥物管理的慢性病的盛行，以及患者對便捷虛擬護理的偏好。遠端醫療平台與藥品福利管理公司 (PBM) 的融合實現了整合服務並增強了依從性追蹤。科技公司正在拓展藥局服務領域，藥師在某些地區也逐漸成為服務提供者。

部分

服務（病患諮詢服務、遠距藥局服務、藥物治療監測服務、處方續藥授權服務）；部署（本地部署、基於 Web 的部署、雲端基礎的部署）

受訪公司範例

  • Advanced Rx Management
  • Alto Pharmacy
  • AMN Healthcare
  • Cardinal Health
  • CarepathRx
  • Cisco Systems
  • Comprehensive Pharmacy Services（CPS）
  • Locke Bio
  • McKesson Ventures
  • Medication Review Inc.
  • MedTel Services
  • North West TelePharmacy Solutions
  • Nurx
  • One Touch Video Chat
  • OSP Labs（telepharmacy solutions）
  • PDS（Pharmacy Delivery Systems）
  • PharmD Live
  • PipelineRx
  • Truepill
  • Zane Networks

人工智慧整合

我們正在利用有效的專家內容和人工智慧工具來改變市場和競爭情報。

Global Industry Analysts 沒有查詢通用的 LLM 或特定產業的SLM，而是建立了一個從世界各地的專家收集的內容庫，其中包括影片錄像、BLOG、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地和進出口（成品和原始設備製造商）情況預測其競爭地位的變化。這種複雜而多面的市場動態預計將以多種方式影響競爭對手，包括銷貨成本(COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他地區

第4章 比賽

簡介目錄
Product Code: MCP39415

Global Telepharmacy Market to Reach US$40.6 Billion by 2030

The global market for Telepharmacy estimated at US$11.7 Billion in the year 2024, is expected to reach US$40.6 Billion by 2030, growing at a CAGR of 23.1% over the analysis period 2024-2030. Patient Counseling Services, one of the segments analyzed in the report, is expected to record a 24.6% CAGR and reach US$20.6 Billion by the end of the analysis period. Growth in the Remote Dispensing Services segment is estimated at 23.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.1 Billion While China is Forecast to Grow at 21.8% CAGR

The Telepharmacy market in the U.S. is estimated at US$3.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$6.2 Billion by the year 2030 trailing a CAGR of 21.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 21.5% and 19.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 16.9% CAGR.

Global Telepharmacy Market - Key Trends & Drivers Summarized

How is Telepharmacy Bridging Gaps in Healthcare Access?

Telepharmacy enables remote delivery of pharmaceutical services-such as medication dispensing, counseling, and therapy monitoring-via digital platforms. Pharmacies use video calls, secure messaging, and robotic dispensing units to serve patients in rural or underserved areas lacking brick-and-mortar pharmacies. Cloud-based pharmacy management systems facilitate prescription verification, electronic health records integration, and adherence tracking. The move from pilot projects to fully integrated telepharmacy networks reflects a shift in how pharmacies are viewed-not just as physical dispensaries, but as healthcare delivery nodes accessible virtually 24/7.

What Technological Advances Are Driving This Evolution?

AI-powered medication review tools now assist pharmacists in identifying drug-drug interactions and personalized dosage adjustments. Automated dispensing kiosks and tele-robotic arms allow remote technicians to oversee safe fulfillment under pharmacist supervision. Tele-pharmaceutical care apps offer features like refill reminders, virtual pill-swallowing coaching, and biometric monitoring for chronic conditions. Blockchain and e-prescription systems improve prescription security and interoperability, while real-time translation modules support non-native speakers in underserved regions. These innovations are reshaping traditional workflow, enabling more efficient, high-quality patient support.

Which Stakeholder Needs Are Steering Telepharmacy Adoption?

Patients with mobility limitations or chronic diseases benefit from home delivery and remote counseling-reducing travel burden and enhancing medication adherence. Employers and insurers see telepharmacy as a way to ensure continuity of care while lowering costs tied to emergency visits. Pharmacies facing workforce shortages leverage telepharmacy to redistribute pharmacist time, support after-hours service, and expand service coverage. Health systems and community hospitals incorporate telepharmacy to comply with regulatory requirements and offer electronic medication reconciliation in rural clinics or during night shifts, improving patient safety in remote settings.

What Is Propelling the Telepharmacy Market Forward?

The growth in the telepharmacy market is driven by several factors including regulatory easing on remote dispensing and e-prescriptions, increased investment in pharmacy automation hardware, rising chronic disease prevalence requiring ongoing medication management, and patient preference for convenient, virtual care. The convergence of telehealth platforms with pharmacy benefit managers (PBMs) enables integrated services and enhanced adherence tracking. Technology companies are expanding into pharmacy services, and pharmacists are gaining provider status in some regions-creating a favorable environment for telepharmacy growth.

SCOPE OF STUDY:

The report analyzes the Telepharmacy market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Services (Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services, Refill Authorization for Prescription Drugs Services); Deployment (On-Premise Deployment, Web-based Deployment, Cloud-based Deployment)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 42 Featured) -

  • Advanced Rx Management
  • Alto Pharmacy
  • AMN Healthcare
  • Cardinal Health
  • CarepathRx
  • Cisco Systems
  • Comprehensive Pharmacy Services (CPS)
  • Locke Bio
  • McKesson Ventures
  • Medication Review Inc.
  • MedTel Services
  • North West TelePharmacy Solutions
  • Nurx
  • One Touch Video Chat
  • OSP Labs (telepharmacy solutions)
  • PDS (Pharmacy Delivery Systems)
  • PharmD Live
  • PipelineRx
  • Truepill
  • Zane Networks

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Telepharmacy - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Medication Access in Remote and Underserved Areas Throws the Spotlight on Telepharmacy
    • Growth in Chronic Disease Management and Medication Adherence Programs Drives Virtual Pharmacy Adoption
    • Integration with EHR and Telemedicine Platforms Strengthens the Business Case for Pharmacist-Led Virtual Consults
    • Post-COVID Acceleration of Digital Health Acceptance Spurs Long-Term Demand for Remote Pharmacy Services
    • Expansion of Mail-Order and E-Prescription Models Enables Seamless Fulfillment Through Telepharmacy Channels
    • Increased Use of Video Counseling and Refill Management Tools Improves Patient Engagement and Compliance
    • Technology Integration with Smart Pill Dispensers and Medication Tracking Apps Expands Ecosystem Reach
    • Rise of D2C Health Startups Creates Strategic Demand for API-Enabled Telepharmacy Infrastructure
    • Growth of Specialty Pharmacy Services Supports Virtual Counseling for Complex Medication Regimens
    • Cost Savings for Healthcare Systems Fuel Adoption of Telepharmacy in Rural and Institutional Settings
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Telepharmacy Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Telepharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Telepharmacy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Patient Counseling Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Patient Counseling Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Remote Dispensing Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Remote Dispensing Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Drug Therapy Monitoring Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Drug Therapy Monitoring Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Refill Authorization for Prescription Drugs Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Refill Authorization for Prescription Drugs Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for On-Premise Deployment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for On-Premise Deployment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Web-based Deployment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Web-based Deployment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Cloud-based Deployment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Cloud-based Deployment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Telepharmacy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 18: USA Recent Past, Current & Future Analysis for Telepharmacy by Services - Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services and Refill Authorization for Prescription Drugs Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 19: USA 6-Year Perspective for Telepharmacy by Services - Percentage Breakdown of Value Sales for Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services and Refill Authorization for Prescription Drugs Services for the Years 2025 & 2030
    • TABLE 20: USA Recent Past, Current & Future Analysis for Telepharmacy by Deployment - On-Premise Deployment, Web-based Deployment and Cloud-based Deployment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA 6-Year Perspective for Telepharmacy by Deployment - Percentage Breakdown of Value Sales for On-Premise Deployment, Web-based Deployment and Cloud-based Deployment for the Years 2025 & 2030
  • CANADA
    • TABLE 22: Canada Recent Past, Current & Future Analysis for Telepharmacy by Services - Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services and Refill Authorization for Prescription Drugs Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 23: Canada 6-Year Perspective for Telepharmacy by Services - Percentage Breakdown of Value Sales for Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services and Refill Authorization for Prescription Drugs Services for the Years 2025 & 2030
    • TABLE 24: Canada Recent Past, Current & Future Analysis for Telepharmacy by Deployment - On-Premise Deployment, Web-based Deployment and Cloud-based Deployment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 25: Canada 6-Year Perspective for Telepharmacy by Deployment - Percentage Breakdown of Value Sales for On-Premise Deployment, Web-based Deployment and Cloud-based Deployment for the Years 2025 & 2030
  • JAPAN
    • Telepharmacy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 26: Japan Recent Past, Current & Future Analysis for Telepharmacy by Services - Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services and Refill Authorization for Prescription Drugs Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Japan 6-Year Perspective for Telepharmacy by Services - Percentage Breakdown of Value Sales for Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services and Refill Authorization for Prescription Drugs Services for the Years 2025 & 2030
    • TABLE 28: Japan Recent Past, Current & Future Analysis for Telepharmacy by Deployment - On-Premise Deployment, Web-based Deployment and Cloud-based Deployment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 29: Japan 6-Year Perspective for Telepharmacy by Deployment - Percentage Breakdown of Value Sales for On-Premise Deployment, Web-based Deployment and Cloud-based Deployment for the Years 2025 & 2030
  • CHINA
    • Telepharmacy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 30: China Recent Past, Current & Future Analysis for Telepharmacy by Services - Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services and Refill Authorization for Prescription Drugs Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 31: China 6-Year Perspective for Telepharmacy by Services - Percentage Breakdown of Value Sales for Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services and Refill Authorization for Prescription Drugs Services for the Years 2025 & 2030
    • TABLE 32: China Recent Past, Current & Future Analysis for Telepharmacy by Deployment - On-Premise Deployment, Web-based Deployment and Cloud-based Deployment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: China 6-Year Perspective for Telepharmacy by Deployment - Percentage Breakdown of Value Sales for On-Premise Deployment, Web-based Deployment and Cloud-based Deployment for the Years 2025 & 2030
  • EUROPE
    • Telepharmacy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 34: Europe Recent Past, Current & Future Analysis for Telepharmacy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 35: Europe 6-Year Perspective for Telepharmacy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 36: Europe Recent Past, Current & Future Analysis for Telepharmacy by Services - Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services and Refill Authorization for Prescription Drugs Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Europe 6-Year Perspective for Telepharmacy by Services - Percentage Breakdown of Value Sales for Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services and Refill Authorization for Prescription Drugs Services for the Years 2025 & 2030
    • TABLE 38: Europe Recent Past, Current & Future Analysis for Telepharmacy by Deployment - On-Premise Deployment, Web-based Deployment and Cloud-based Deployment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Europe 6-Year Perspective for Telepharmacy by Deployment - Percentage Breakdown of Value Sales for On-Premise Deployment, Web-based Deployment and Cloud-based Deployment for the Years 2025 & 2030
  • FRANCE
    • Telepharmacy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 40: France Recent Past, Current & Future Analysis for Telepharmacy by Services - Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services and Refill Authorization for Prescription Drugs Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 41: France 6-Year Perspective for Telepharmacy by Services - Percentage Breakdown of Value Sales for Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services and Refill Authorization for Prescription Drugs Services for the Years 2025 & 2030
    • TABLE 42: France Recent Past, Current & Future Analysis for Telepharmacy by Deployment - On-Premise Deployment, Web-based Deployment and Cloud-based Deployment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 43: France 6-Year Perspective for Telepharmacy by Deployment - Percentage Breakdown of Value Sales for On-Premise Deployment, Web-based Deployment and Cloud-based Deployment for the Years 2025 & 2030
  • GERMANY
    • Telepharmacy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 44: Germany Recent Past, Current & Future Analysis for Telepharmacy by Services - Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services and Refill Authorization for Prescription Drugs Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Germany 6-Year Perspective for Telepharmacy by Services - Percentage Breakdown of Value Sales for Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services and Refill Authorization for Prescription Drugs Services for the Years 2025 & 2030
    • TABLE 46: Germany Recent Past, Current & Future Analysis for Telepharmacy by Deployment - On-Premise Deployment, Web-based Deployment and Cloud-based Deployment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Germany 6-Year Perspective for Telepharmacy by Deployment - Percentage Breakdown of Value Sales for On-Premise Deployment, Web-based Deployment and Cloud-based Deployment for the Years 2025 & 2030
  • ITALY
    • TABLE 48: Italy Recent Past, Current & Future Analysis for Telepharmacy by Services - Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services and Refill Authorization for Prescription Drugs Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Italy 6-Year Perspective for Telepharmacy by Services - Percentage Breakdown of Value Sales for Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services and Refill Authorization for Prescription Drugs Services for the Years 2025 & 2030
    • TABLE 50: Italy Recent Past, Current & Future Analysis for Telepharmacy by Deployment - On-Premise Deployment, Web-based Deployment and Cloud-based Deployment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Italy 6-Year Perspective for Telepharmacy by Deployment - Percentage Breakdown of Value Sales for On-Premise Deployment, Web-based Deployment and Cloud-based Deployment for the Years 2025 & 2030
  • UNITED KINGDOM
    • Telepharmacy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 52: UK Recent Past, Current & Future Analysis for Telepharmacy by Services - Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services and Refill Authorization for Prescription Drugs Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 53: UK 6-Year Perspective for Telepharmacy by Services - Percentage Breakdown of Value Sales for Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services and Refill Authorization for Prescription Drugs Services for the Years 2025 & 2030
    • TABLE 54: UK Recent Past, Current & Future Analysis for Telepharmacy by Deployment - On-Premise Deployment, Web-based Deployment and Cloud-based Deployment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 55: UK 6-Year Perspective for Telepharmacy by Deployment - Percentage Breakdown of Value Sales for On-Premise Deployment, Web-based Deployment and Cloud-based Deployment for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 56: Rest of Europe Recent Past, Current & Future Analysis for Telepharmacy by Services - Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services and Refill Authorization for Prescription Drugs Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Rest of Europe 6-Year Perspective for Telepharmacy by Services - Percentage Breakdown of Value Sales for Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services and Refill Authorization for Prescription Drugs Services for the Years 2025 & 2030
    • TABLE 58: Rest of Europe Recent Past, Current & Future Analysis for Telepharmacy by Deployment - On-Premise Deployment, Web-based Deployment and Cloud-based Deployment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Rest of Europe 6-Year Perspective for Telepharmacy by Deployment - Percentage Breakdown of Value Sales for On-Premise Deployment, Web-based Deployment and Cloud-based Deployment for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Telepharmacy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 60: Asia-Pacific Recent Past, Current & Future Analysis for Telepharmacy by Services - Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services and Refill Authorization for Prescription Drugs Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Asia-Pacific 6-Year Perspective for Telepharmacy by Services - Percentage Breakdown of Value Sales for Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services and Refill Authorization for Prescription Drugs Services for the Years 2025 & 2030
    • TABLE 62: Asia-Pacific Recent Past, Current & Future Analysis for Telepharmacy by Deployment - On-Premise Deployment, Web-based Deployment and Cloud-based Deployment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Asia-Pacific 6-Year Perspective for Telepharmacy by Deployment - Percentage Breakdown of Value Sales for On-Premise Deployment, Web-based Deployment and Cloud-based Deployment for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 64: Rest of World Recent Past, Current & Future Analysis for Telepharmacy by Services - Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services and Refill Authorization for Prescription Drugs Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Rest of World 6-Year Perspective for Telepharmacy by Services - Percentage Breakdown of Value Sales for Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services and Refill Authorization for Prescription Drugs Services for the Years 2025 & 2030
    • TABLE 66: Rest of World Recent Past, Current & Future Analysis for Telepharmacy by Deployment - On-Premise Deployment, Web-based Deployment and Cloud-based Deployment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Rest of World 6-Year Perspective for Telepharmacy by Deployment - Percentage Breakdown of Value Sales for On-Premise Deployment, Web-based Deployment and Cloud-based Deployment for the Years 2025 & 2030

IV. COMPETITION